Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1

Rebecca A. Buonpane, Beenu Moza, Eric J. Sundberg, David M. Kranz

Research output: Contribution to journalArticle

Abstract

Superantigens, including bacterial enterotoxins, are a family of proteins that bind simultaneously to MHC class II molecules and the Vβ regions of T cell receptors. This cross-linking results in the activation of a large population of T cells that release massive amounts of inflammatory cytokines, ultimately causing a condition known as toxic shock syndrome. The staphylococcal superantigen toxic shock syndrome toxin-1 (TSST-1) is a causative agent of this disease, but its structure in complex with the cognate T cell receptor (human Vβ2.1) has not been determined. To understand the molecular details of the interaction and to develop high affinity antagonists to TSST-1, we used directed evolution to generate a panel of high affinity receptors for TSST-1. Yeast display libraries of random and site-directed hVβ2.1 mutants were selected for improved domain stability and for higher affinity binding to TSST-1. Stability mutations allowed the individual Vβ domains to be expressed in a bacterial expression system. Affinity mutations were generated in CDR2 and FR3 residues, yielding improvements in affinity of greater than 10,000-fold (a KD value of 180 pmol). Alanine scanning mutagenesis of hVβ2.1 wild-type and mutated residues allowed us to generate a map of the binding site for TSST-1 and to construct a docking model for the hVβ2.1-TSST-1 complex. Our experiments suggest that the energetic importance of a single hVβ2.1 wild-type residue likely accounts for the restriction of TSST-1 specificity to only this human Vβ region. The high affinity mutants described here thus provide critical insight into the molecular basis of TSST-1 specificity and serve as potential leads toward the development of therapeutic agents for superantigen-mediated disease.

Original languageEnglish (US)
Pages (from-to)308-321
Number of pages14
JournalJournal of Molecular Biology
Volume353
Issue number2
DOIs
StatePublished - Oct 21 2005

Fingerprint

T-Cell Antigen Receptor
Superantigens
Mutation
Staphylococcal enterotoxin F
Enterotoxins
Septic Shock
Mutagenesis
Alanine
Yeasts
Binding Sites
Cytokines
T-Lymphocytes
Population

Keywords

  • Bacterial superantigens
  • Enterotoxins
  • Protein engineering
  • Toxic shock syndrome
  • Yeast display

ASJC Scopus subject areas

  • Structural Biology
  • Molecular Biology

Cite this

Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1. / Buonpane, Rebecca A.; Moza, Beenu; Sundberg, Eric J.; Kranz, David M.

In: Journal of Molecular Biology, Vol. 353, No. 2, 21.10.2005, p. 308-321.

Research output: Contribution to journalArticle

Buonpane, Rebecca A. ; Moza, Beenu ; Sundberg, Eric J. ; Kranz, David M. / Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1. In: Journal of Molecular Biology. 2005 ; Vol. 353, No. 2. pp. 308-321.
@article{d38d371244754c73b15a295bd802e73f,
title = "Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1",
abstract = "Superantigens, including bacterial enterotoxins, are a family of proteins that bind simultaneously to MHC class II molecules and the Vβ regions of T cell receptors. This cross-linking results in the activation of a large population of T cells that release massive amounts of inflammatory cytokines, ultimately causing a condition known as toxic shock syndrome. The staphylococcal superantigen toxic shock syndrome toxin-1 (TSST-1) is a causative agent of this disease, but its structure in complex with the cognate T cell receptor (human Vβ2.1) has not been determined. To understand the molecular details of the interaction and to develop high affinity antagonists to TSST-1, we used directed evolution to generate a panel of high affinity receptors for TSST-1. Yeast display libraries of random and site-directed hVβ2.1 mutants were selected for improved domain stability and for higher affinity binding to TSST-1. Stability mutations allowed the individual Vβ domains to be expressed in a bacterial expression system. Affinity mutations were generated in CDR2 and FR3 residues, yielding improvements in affinity of greater than 10,000-fold (a KD value of 180 pmol). Alanine scanning mutagenesis of hVβ2.1 wild-type and mutated residues allowed us to generate a map of the binding site for TSST-1 and to construct a docking model for the hVβ2.1-TSST-1 complex. Our experiments suggest that the energetic importance of a single hVβ2.1 wild-type residue likely accounts for the restriction of TSST-1 specificity to only this human Vβ region. The high affinity mutants described here thus provide critical insight into the molecular basis of TSST-1 specificity and serve as potential leads toward the development of therapeutic agents for superantigen-mediated disease.",
keywords = "Bacterial superantigens, Enterotoxins, Protein engineering, Toxic shock syndrome, Yeast display",
author = "Buonpane, {Rebecca A.} and Beenu Moza and Sundberg, {Eric J.} and Kranz, {David M.}",
year = "2005",
month = "10",
day = "21",
doi = "10.1016/j.jmb.2005.08.041",
language = "English (US)",
volume = "353",
pages = "308--321",
journal = "Journal of Molecular Biology",
issn = "0022-2836",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1

AU - Buonpane, Rebecca A.

AU - Moza, Beenu

AU - Sundberg, Eric J.

AU - Kranz, David M.

PY - 2005/10/21

Y1 - 2005/10/21

N2 - Superantigens, including bacterial enterotoxins, are a family of proteins that bind simultaneously to MHC class II molecules and the Vβ regions of T cell receptors. This cross-linking results in the activation of a large population of T cells that release massive amounts of inflammatory cytokines, ultimately causing a condition known as toxic shock syndrome. The staphylococcal superantigen toxic shock syndrome toxin-1 (TSST-1) is a causative agent of this disease, but its structure in complex with the cognate T cell receptor (human Vβ2.1) has not been determined. To understand the molecular details of the interaction and to develop high affinity antagonists to TSST-1, we used directed evolution to generate a panel of high affinity receptors for TSST-1. Yeast display libraries of random and site-directed hVβ2.1 mutants were selected for improved domain stability and for higher affinity binding to TSST-1. Stability mutations allowed the individual Vβ domains to be expressed in a bacterial expression system. Affinity mutations were generated in CDR2 and FR3 residues, yielding improvements in affinity of greater than 10,000-fold (a KD value of 180 pmol). Alanine scanning mutagenesis of hVβ2.1 wild-type and mutated residues allowed us to generate a map of the binding site for TSST-1 and to construct a docking model for the hVβ2.1-TSST-1 complex. Our experiments suggest that the energetic importance of a single hVβ2.1 wild-type residue likely accounts for the restriction of TSST-1 specificity to only this human Vβ region. The high affinity mutants described here thus provide critical insight into the molecular basis of TSST-1 specificity and serve as potential leads toward the development of therapeutic agents for superantigen-mediated disease.

AB - Superantigens, including bacterial enterotoxins, are a family of proteins that bind simultaneously to MHC class II molecules and the Vβ regions of T cell receptors. This cross-linking results in the activation of a large population of T cells that release massive amounts of inflammatory cytokines, ultimately causing a condition known as toxic shock syndrome. The staphylococcal superantigen toxic shock syndrome toxin-1 (TSST-1) is a causative agent of this disease, but its structure in complex with the cognate T cell receptor (human Vβ2.1) has not been determined. To understand the molecular details of the interaction and to develop high affinity antagonists to TSST-1, we used directed evolution to generate a panel of high affinity receptors for TSST-1. Yeast display libraries of random and site-directed hVβ2.1 mutants were selected for improved domain stability and for higher affinity binding to TSST-1. Stability mutations allowed the individual Vβ domains to be expressed in a bacterial expression system. Affinity mutations were generated in CDR2 and FR3 residues, yielding improvements in affinity of greater than 10,000-fold (a KD value of 180 pmol). Alanine scanning mutagenesis of hVβ2.1 wild-type and mutated residues allowed us to generate a map of the binding site for TSST-1 and to construct a docking model for the hVβ2.1-TSST-1 complex. Our experiments suggest that the energetic importance of a single hVβ2.1 wild-type residue likely accounts for the restriction of TSST-1 specificity to only this human Vβ region. The high affinity mutants described here thus provide critical insight into the molecular basis of TSST-1 specificity and serve as potential leads toward the development of therapeutic agents for superantigen-mediated disease.

KW - Bacterial superantigens

KW - Enterotoxins

KW - Protein engineering

KW - Toxic shock syndrome

KW - Yeast display

UR - http://www.scopus.com/inward/record.url?scp=25144479800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144479800&partnerID=8YFLogxK

U2 - 10.1016/j.jmb.2005.08.041

DO - 10.1016/j.jmb.2005.08.041

M3 - Article

C2 - 16171815

AN - SCOPUS:25144479800

VL - 353

SP - 308

EP - 321

JO - Journal of Molecular Biology

JF - Journal of Molecular Biology

SN - 0022-2836

IS - 2

ER -